StreetInsider.com News Articles

Apptly Health closes first tranche of private placement at $0.125

Tue, 06 Oct 2026 19:29:12 -0400

Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) has completed the first tranche of a non-brokered private placement, issuing 5,811,600 units at $0.125 per unit for gross proceeds of $726,450, according to a company statement.

Each unit consists of one common share and one warrant exercisable at $0.25 per share for 12 months following the October 6, 2026 closing date. The company may accelerate warrant expiry if the share price on the Canadian Securities Exchange equals or exceeds $0.35 for 30 consecutive trading days, giving warrant holders 30 days' notice before expiration.

The company paid $2,975 in finder's fees and issued 23,800

Apptly Closes First Tranche of Non-Brokered Private Placement

Tue, 06 Oct 2026 19:27:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - October 6, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company") is pleased to announce that it has completed the first tranche of its previously announced non-brokered private placement offering (the "Offering"), issuing 5,811,600 units of the Company (the "Units") at a price equal to $0.125 per Unit (the "Offering Price") for aggregate gross proceeds of $726,450.

Each Unit is comprised of one common share of the Company (each, a "Share") and one common share purchase warrant of the Company (each, a "Warrant"). Each Warrant is exercisable to acquire one (1) Share at

Apptly Closes First Tranche of Non-Brokered Private Placement

Tue, 06 Oct 2026 19:27:00 -0400

Apptly Health Technologies to Present at the Life Sciences Investor Forum on September 17th

Thu, 17 Sep 2026 14:43:00 -0400

BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Apptly Health Technologies (OTCQB: APTHF; CSE:APPT), based in Boston, focused on Digital health and direct pay healthcare, today announced that Dr. Paula Muto, CEO and Founder, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026

DATE: September 17th
TIME: 1:30 PM ET

REGISTER HERE

Schedule 1x1 meetings here.

The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the

Apptly Health Technologies to Present at the Life Sciences Investor Forum on September 17th

Thu, 17 Sep 2026 14:43:00 -0400

DATE: September 17th
TIME: 1:30 PM ET

REGISTER HERE

Schedule 1x1 meetings here.

The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the

Apptly Health Technologies to Present at the Life Sciences Investor Forum on September 17th

Thu, 17 Sep 2026 14:43:00 -0400

DATE: September 17th
TIME: 1:30 PM ET

REGISTER HERE

Schedule 1x1 meetings here.

The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the

Apptly Health Technologies to Present at the Life Sciences Investor Forum on September 17th

Thu, 17 Sep 2026 14:43:00 -0400

DATE: September 17th
TIME: 1:30 PM ET

REGISTER HERE

Schedule 1x1 meetings here.

The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the

Apptly Commences Trading on the OTCQB and Becomes DTC Eligible

Wed, 02 Sep 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 2, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced that it has been approved to trade on the OTCQB Venture Market ("OTCQB") in the United States under the symbol "ESVNF", effective September 2, 2026. The Company also confirms that its common shares are eligible for electronic clearing and settlement through the Depository Trust Company ("DTC").

Together, the OTCQB listing and DTC eligibility are expected to improve liquidity and visibility among US investors as the Company broadens its shareholder base.

"OTCQB approval

Apptly Commences Trading on the OTCQB and Becomes DTC Eligible

Wed, 02 Sep 2026 08:00:00 -0400

Together, the OTCQB listing and DTC eligibility are expected to improve liquidity and visibility among US investors as the Company broadens its shareholder base.

"OTCQB approval

Apptly Commences Trading on the OTCQB and Becomes DTC Eligible

Wed, 02 Sep 2026 08:00:00 -0400

Together, the OTCQB listing and DTC eligibility are expected to improve liquidity and visibility among US investors as the Company broadens its shareholder base.

"OTCQB approval

Apptly Commences Trading on the OTCQB and Becomes DTC Eligible

Wed, 02 Sep 2026 08:00:00 -0400

Together, the OTCQB listing and DTC eligibility are expected to improve liquidity and visibility among US investors as the Company broadens its shareholder base.

"OTCQB approval

Apptly and Koning partner on breast CT marketplace access

Tue, 01 Sep 2026 08:02:48 -0400

Apptly Health Technologies Corp. (CSE: APPT, FSE: 4KL) announced a partnership with Koning Corporation to list Koning Vera Breast CT imaging services on Apptly's UberDoc direct-pay healthcare marketplace, according to a company press release.

Under the agreement, Koning will display UberDoc physician and service listings within its platform and introduce its provider sites to UberDoc for potential onboarding. Apptly will supply physician and service data along with trackable links allowing patients on Koning's platform to book appointments directly through UberDoc. The companies also plan joint marketing activity and will explore potential technology integrations for cash-pay appointments.

The Koning Vera Breast CT holds

Apptly and Koning Announce Strategic Partnership to Expand Patient Access to Non-Compression 3D Breast Imaging

Tue, 01 Sep 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced a strategic partnership with Koning Corporation ("Koning"), manufacturer of the FDA-approved Koning Vera Breast CT.

Highlights:

FDA-Approved Breast CT: The Koning Vera Breast CT is the only breast CT system with FDA premarket approval for diagnostic imaging of the breast.
Market Access Model: Koning gains direct reach to patients already searching for care and ready to pay, while UberDoc adds imaging sites to its marketplace at transparent, upfront prices.
Clinical Need: Mammography may

Apptly and Koning Announce Strategic Partnership to Expand Patient Access to Non-Compression 3D Breast Imaging

Tue, 01 Sep 2026 08:00:00 -0400

Highlights:

FDA-Approved Breast CT: The Koning Vera Breast CT is the only breast CT system with FDA premarket approval for diagnostic imaging of the breast.
Market Access Model: Koning gains direct reach to patients already searching for care and ready to pay, while UberDoc adds imaging sites to its marketplace at transparent, upfront prices.
Clinical Need: Mammography may

UberDoc partners with XY.AI Labs to expand physician AI access

Thu, 30 Apr 2026 08:01:34 -0400

UberDoc Health Technologies Corp. (CSE: APPT | FSE: 4KL0) announced a partnership with XY.AI Labs to connect independent medical practices with AI-driven operational tools and direct-pay healthcare services.

The agreement allows XY.AI Labs to introduce UberDoc's direct-pay specialist marketplace to physicians in its network as an alternative revenue source to insurance-dependent payments. UberDoc will connect its network of more than 5,000 specialists across all 50 states with XY.AI Labs' platform of AI agents designed for healthcare operations.

XY.AI Labs' platform automates practice workflows including scheduling, insurance verification, prior authorization, medical coding, and billing support. UberDoc operates a marketplace connecting patients with specialists

UberDoc partners with XY.AI Labs to expand physician AI access

Thu, 30 Apr 2026 08:01:34 -0400

UberDoc partners with XY.AI Labs to expand physician AI access

Thu, 30 Apr 2026 08:01:34 -0400

UberDoc Health Technologies Announces Strategic Partnership with XY.AI Labs to Expand Physician Network and Advance AI-Driven Practice Support